PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
33178594-8	2020	Inhibition of GSK-3beta by 1-Azakenpaullone could partially reverse the effects of BYSL downregulation on the transcriptional activity of beta-catenin, the expression of EMT markers, and GBM cell migration/invasion.	kenpaullone	27-43	glycogen synthase kinase 3 alpha	Homo sapiens	14-23	
34635948-4	2021	Here, we investigate the morphological effects of 1-azakenpaullone, a pharmacological inhibitor of GSK3beta that is supposed to over-activate the Wnt/beta-catenin pathway, during the anterior and posterior regeneration of the annelid Syllis malaquini.	kenpaullone	50-66	glycogen synthase kinase 3 alpha	Homo sapiens	99-107	
15522889-3	2004	Two chemical inhibitors of glycogen synthase kinase (GSK)-3beta, indirubin-3-monoxime and kenpaullone, were found to increase neuronal differentiation in ventral mesencephalon precursor cultures.	kenpaullone	90-101	glycogen synthase kinase 3 alpha	Homo sapiens	27-63	
15522889-4	2004	In addition, the GSK-3beta-specific inhibitor kenpaullone increased the size of the DA neuron population through conversion of precursors expressing the orphan nuclear receptor-related factor 1 into tyrosine hydroxylase positive neurons, thereby mimicking an effect of Wnts.	kenpaullone	46-57	glycogen synthase kinase 3 alpha	Homo sapiens	17-26	
23565238-4	2013	CG0009 enhanced the inactivating phosphorylation of GSK3alpha at Ser21 and GSK3beta at Ser9 and simultaneously decreased activating phosphorylation of GSK3beta at Tyr216, and induced caspase-dependent apoptosis independently of estrogen receptor alpha (ERalpha) expression status, which was not observed with the other GSK3 inhibitors examined, including SB216763, kenpaullone and LiCl.	kenpaullone	365-376	glycogen synthase kinase 3 alpha	Homo sapiens	52-61